A detailed history of Principal Securities, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Principal Securities, Inc. holds 227 shares of OGN stock, worth $3,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
227
Previous 589 61.46%
Holding current value
$3,309
Previous $12.2 Million 64.38%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$18.65 - $23.03 $6,751 - $8,336
-362 Reduced 61.46%
227 $4.34 Million
Q2 2024

Jul 31, 2024

BUY
$17.45 - $21.96 $2,582 - $3,250
148 Added 33.56%
589 $12.2 Million
Q1 2024

May 10, 2024

BUY
$13.78 - $18.8 $3,238 - $4,418
235 Added 114.08%
441 $8.29 Million
Q4 2023

Feb 07, 2024

BUY
$10.95 - $17.32 $2,255 - $3,567
206 New
206 $2.97 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.